 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Food and Drug Administration</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>21 CFR Part 358</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 81N&hyph;0201]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Marketing of Over-the-Counter Pediculicide Drug Products; Background Documents; Availability 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Food and Drug Administration, HHS.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Availability of background documents.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Food and Drug Administration (FDA) is announcing the availability of background documents dealing with its response
to two citizen petitions seeking actions for marketing of over-the-counter (OTC) pediculicide drug products. This
action is being taken to ensure that all interested persons are aware of the issues that were raised in the two citizen
petitions. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Single copies of the background documents may be requested in writing from the Freedom of Information Staff (HFI&hyph;35),
Food and Drug Administration, rm. 12A&hyph;16, 5600 Fishers Lane, Rockville, MD 20857, at a cost of 10 cents per page.
Requests should be identified with the docket number found in brackets in the heading of this document. The background
documents are available for public examination at the Dockets Management Branch (HFA&hyph;305), Food and Drug Administration,
rm. 1&hyph;23, 12420 Parklawn Dr., Rockville, MD 20857, between 9 a.m. and 4 p.m., Monday through Friday.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
William E. Gilbertson, Center for Drug Evaluation and Research (HFD&hyph;810), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857, 301&hyph;594&hyph;5000.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 of 
<!-- PJG 0012 frnewline -->
December 14, 1993 (58 FR 65452), FDA issued a final monograph for OTC pediculicide drug products (21 CFR part 358, subpart
G). The final monograph becomes effective on December 14, 1994. Prior to that date, jurisdiction over pediculicide
products is vested concurrently with the Environmental Protection Agency (EPA) and with FDA. EPA and FDA labeling
requirements for these products are different. After December 14, 1994, FDA will have sole jurisdiction over labeling
and other requirements applicable to OTC pediculicide drug products. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On February 25, 1994, the Nonprescription Drug Manufacturers Association (NDMA) submitted a citizen petition (Ref.
1) requesting certain actions because of the dual jurisdiction over OTC pediculicide drug products that exists until
December 14, 1994. On April 14, 1994, a meeting was held between FDA, EPA, and NDMA (Ref. 2). On April 22, 1994, NDMA submitted
a second, more detailed citizen petition (Ref. 3). NDMA requested FDA to provide industry at least 1 1/2 years from
December 14, 1993 (the date of publication of the final monograph for OTC pediculicide drug products), for a smooth
transition from EPA to FDA regulations for OTC pediculicide drug products. NDMA also requested FDA agreement not
to bring enforcement proceedings against OTC pediculicide drug products applied to the human body and bearing EPA-mandated
labeling for 1 year after December 14, 1994. The enforcement deferral would apply to products distributed with labeling
printed before December 14, 1994, or where the products shipped into interstate commerce had been in stock before
December 14, 1994. NDMA also submitted a citizen petition to EPA, which responded by notice dated September 6, 1994
(Ref. 4). 
<!-- PJG 0012 frnewline -->
FDA responded to NDMA (Refs. 5 and 6) stating that a 11/2 year extension to meet FDA labeling requirements would not
be granted on a blanket basis for all products. The agency stated that requests for extensions would be evaluated on
a case-by-case basis. The agency also indicated that any extension granted will be limited to the quantity of stock
that a company has on hand prior to December 14, 1994. FDA also stated that, in its discretion, it agrees not to bring
enforcement proceedings against OTC pediculicide drug products conforming with the final monograph and containing
EPA-required labeling for a period of 1 year after the effective date of the final monograph on December 14, 1994.
<!-- PJG 0012 frnewline -->
FDA has placed all of the correspondence on this subject in docket no. 81N&hyph;0201 for OTC pediculicide drug products,
to enable interested persons to see the correspondence. The documents may be seen in the Dockets Management Branch
(address above) between 9 a.m. and 4 p.m., Monday through Friday.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
References
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
(1) Citizen petition from the Nonprescription Drug Manufacturers Association to FDA, coded CP1, Docket No. 81N&hyph;0201,
Dockets Management Branch.
<!-- PJG 0012 frnewline -->
(2) Memorandum of Meeting, coded MM1, Docket No. 81N&hyph;0201, Dockets Management Branch.
<!-- PJG 0012 frnewline -->
(3) Citizen petition from the Nonprescription Drug Manufacturers Association to FDA, coded CP2, Docket No. 81N&hyph;0201,
Dockets Management Branch.
<!-- PJG 0012 frnewline -->
(4) Pesticide Regulation Notice 94&hyph;6, dated September 6, 1994, Notice to Manufacturers, Producers, Formulators,
and Registrants of Pesticide Products, Office of Pesticides and Toxic Substances, Environmental Protection Agency,
coded REF1, Docket No. 81N&hyph;0201, Dockets Management Branch.
<!-- PJG 0012 frnewline -->
(5) Letter from W. E. Gilbertson, FDA, to R. W. Soller, Nonprescription Drug Manufacturers Association, coded LET18,
Docket No. 81N&hyph;0201, Dockets Management Branch. 
<!-- PJG 0012 frnewline -->
(6) Letter from R. G. Chesemore, FDA, to R. W. Soller, Nonprescription Drug Manufacturers Association, coded PAV1,
Docket No. 81N&hyph;0201, Dockets Management Branch.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: November 30, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
William K. Hubbard,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Interim Deputy Commissioner for Policy.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;29987 Filed 12&hyph;5&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;01&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
